Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

deferoxamine mesylate for injection, USP Indications and Usage


1.1 Acute Iron Intoxication

Deferoxamine Mesylate for injection is indicated as an adjunct to standard measures for the treatment of acute iron intoxication.

1.2 Chronic Iron Overload

Deferoxamine mesylate is indicated for the treatment of transfusional iron overload in patients with chronic anemia.

1.3 Limitations of Use

Deferoxamine mesylate is not indicated for the treatment of primary hemochromatosis (since phlebotomy is the method of choice for removing excess iron in this disorder).

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event